AvenCell

Watertown, MA · Founded 2021 · Privately Held (backing)

Developer of T cell-based immunotherapies intended to support cancer treatment. AvenCell is based in Watertown, MA and was founded in 2021. Its last reported valuation was $227 million in Oct 2024. It has raised $192 million.

Last reported valuation

$227.0M

Oct 2026

Priced at

—

Total raised

$192.4M

Last round

—

How much has AvenCell raised?

$192.4Macross 0 recorded rounds

Free account

More of AvenCell with a free account

·Watch AvenCell: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

AvenCell investors

10 investors are on record for AvenCell, including F-Prime Capital, Eight Roads, Novo Holdings and NYBC Ventures.

For fundraisers

Raising for a company like AvenCell?

10 investors have backed AvenCell.

See all 10 investors →

Frequently asked about AvenCell

How much has AvenCell raised?: AvenCell has raised $192.4M in total across 0 recorded funding rounds.